PDE8A anticorps (C-Term)
Aperçu rapide pour PDE8A anticorps (C-Term) (ABIN928993)
Antigène
Voir toutes PDE8A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Purified
-
Immunogène
- PDE8 A antibody was raised in rabbit using the C terminal of PDE8 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
PDE8A Blocking Peptide, (ABIN5615278), is also available for use as a blocking control in assays to test for specificity of this PDE8A antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- PDE8A (phosphodiesterase 8A (PDE8A))
-
Autre désignation
- PDE8A
-
Sujet
- Phosphodiesterases (PDEs) regulate the intracellular levels of cAMP and cGMP. These cyclic nucleotides play an important role as second messengers in multiple physiologic processes, including regulation of vascular resistance, cardiac output, visceral motility, immune response, inflammation, neuroplasticity, vision, and reproduction. PDEs comprise a large superfamily of enzymes divided into 10 families. Different PDEs can be distinguished by their structure, tissue expression, localization, substrate specificity, regulation, and sensitivity to PDE inhibitors. Diversity in structure and specificity of function make PDEs promising targets for the pharmacotherapy of diseases modulated by cyclic nucleotide signaling. Synonyms: Polyclonal PDE8A antibody, Anti-PDE8A antibody, phosphodiesterase 8A antibody, FLJ16150 antibody, HsT19550 antibody.
-
Pathways
- cAMP Metabolic Process
Antigène
-